Dear Colleagues,
It is my pleasure to meet you all through the October 2013 edition of Oviya MedSafe’s newsletter and greet you during this festive season!
I am glad to announce that Oviya MedSafe now introduces the offering of end-to-end pharmacovigilance services bundled with hosted E2B-compliant drug safety database solutions, which would be of remarkable benefit to small and mid-sized pharmaceutical companies by way of enabling them to be compliant with drug regulations without incurring enormous fixed costs pertaining to the investments that need to be made for installing pharmacovigilance databases in their premises for their exclusive use. 
With more and more of generic pharmaceutical companies wanting to comply with drug regulations worldwide, we believe this bundled service will be a great value addition to marketing authorization holders across the globe, especially when the number of adverse event reports they expect to handle is either minimal or too variable to predict. Oviya MedSafe believes that this bundled service is the need of the hour, as pharmacovigilance is coming of age in emerging economies also.
On this occasion, I am happy to share with you my interview titled Thalidomide Tragedy Revisited which has been published on account of the 50th anniversary of the Thalidomide Tragedy, in the September 2013 issue of Pharma Bio World – a popular pharmaceutical and biotechnology industry magazine published from Mumbai. Thanks to the interviewer Ms Ananya Sen, I had an opportunity to emphasize on the significance of pharmacovigilance and express my views on what all of us have learnt about drug safety as a science during this period of 50 years. Please click here to read the interview and share your feedback.
Before signing off for the month, I take the privilege of inviting you to visit Oviya MedSafe’s stall at the 5th Pharmacovigilance Congregation 2013, for which Oviya MedSafe is a Bronze Sponsor. As you might know, the event is being organized by Virtue Insight on November 20, 2013 at Kohinoor Continental Hotel, Mumbai.
Looking forward to meeting you with more advancements in November 2013,
With thanks & regards, 
Dr J Vijay Venkatraman 
MBBS, F. Diab., MBA 
Managing Director & CEO, 
Oviya MedSafe Pvt. Ltd. 
Pharmacovigilance Consulting & Services
2nd Floor, KTVR Gardens,
220a-3, Marudha Konar Road,
Coimbatore – 641 025.
Tamil Nadu, India.
Office Mobile: +91-94422-25311
Office Phone:  +91-422-2444442 

Leave a comment

Your email address will not be published. Required fields are marked *